Navigation Links
Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT
Date:7/29/2008

2008 American College of Chest Physicians (ACCP) Guidelines Will Increase

Use of Trellis(R) Peripheral Infusion System

NORTHBROOK, Ill., July 29 /PRNewswire/ -- The American College of Chest Physicians (ACCP) has published new evidence-based clinical guidelines for physicians that for the first time suggest the use of pharmacomechanical thrombolysis for acute iliofemoral deep vein thrombosis (DVT) in conjunction with anticoagulation drug therapy. The new guidelines appear in the July supplement to the CHEST journal.

"This is a major change in the recommendations for the care of these patients with extensive DVT, and represents a major advance in treatment. Adopting an initial strategy of thrombus removal will improve the quality of life of these patients and potentially avoid recurrent DVT in the future," stated Anthony J. Comerota, MD, FACS, FACC, Director of the Jobst Vascular Center and Adjunct Professor of Surgery, University of Michigan.

"The recommendation to treat certain cases of acute DVT with pharmacomechanical thrombolysis adds an important tool to help treat the acute problem as well as to minimize the long-term disability of post-thrombotic syndrome (PTS) in patients," added Katharine L. Krol, MD, Director, Vascular Interventional Radiology, CorVasc MDs, Indianapolis, IN and recent past president of the Society of Interventional Radiology (SIR).

The new Venous Thromboembolic (VTE) Disease guidelines represent an evolution from the previous ACCP standard which recommended the use of anticoagulation drug therapy alone for the treatment of DVT. For complete information on the new ACCP VTE Guidelines, visit http://www.TheNewGuidelines.org.

While anticoagulation alone mitigates the risk of clot propagation and pulmonary embolism, it often fails to clear the blockage. This residual thrombus can lead to venous hypertension, valvular insufficiency, skin ulcerations and post-thrombotic syndrome.

"The publication of the new 2008 ACCP guidelines suggesting the use of pharmacomechanical thrombolysis clearly establishes a new standard for thrombolytic therapy. We believe the Trellis(R) Isolated Pharmacomechanical Thrombolysis method provides the best available combination of safety and efficacy," remarked Scott Cramer, President and CEO of Bacchus Vascular, Inc.

Isolated pharmacomechanical thrombolysis using the Trellis Peripheral Infusion System from Bacchus Vascular, Inc. to deliver thrombolytic directly into a desired treatment segment has proven to be a rapid, effective and safe method of treating patients with acute DVT. The Trellis device is the only DVT treatment system that isolates the thrombus and targets the thrombolytic treatment.

About Bacchus Vascular

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.

For more information, visit http://www.bacchusvascular.com.

For complete information on the new ACCP VTE Guidelines, visit: http://www.TheNewGuidelines.org.


'/>"/>
SOURCE Bacchus Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31, 2008
2. Medline Signs 3-Year Purchasing Agreement for Mouth Rinse From Chester Labs
3. Rochester Medical Announces Second Quarter 2008 Earnings Conference Call April 29, 2008
4. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
5. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
6. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
7. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
8. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
9. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
10. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
11. More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Margot Connor, CEO ... on Baltimore Business Journal’s 2017 Tech 10 List of “outstanding professionals in the ... for contributions to the technology industry within their local community. Honorees are “CEOs ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... (AI) and leading supplier of Semantic Graph Database technology for Knowledge Graphs, today ... and discovering connections within data. Gruff provides novice users and graph experts the ...
(Date:7/26/2017)... , ... July 25, 2017 , ... ... proud to announce that its regenerative stem cell therapy has been used on ... a successful treatment for horses with potentially fatal injuries to tendons and ligaments. ...
(Date:7/26/2017)... Minneapolis, MN (PRWEB) , ... July 26, 2017 ... ... All of Us Research Program at the National Institutes of Health (NIH), will ... Medicine Conference. This annual conference provides a platform for a multi-stakeholder discussion on ...
Breaking Biology Technology:
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Biology News(10 mins):